Stoke Therapeutics, Inc 10-Q for FY2025 Q1
Stoke Therapeutics, Inc. (STOK)
10-Q
2025-05-13
For: 2025-03-31
View Original
Added on
April 08, 2026
About this 10-Q
Stoke Therapeutics, Inc filed this 10-Q on May 13, 2025, covering the quarter ended March 31, 2025 (FY2025 Q1).
Headline figures
Quarter ended March 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $158.57M
- up 3661.1% from $4.22M a year earlier
- Net income
- $112.88M
- compared with a net loss of $26.37M a year earlier
- Diluted EPS
- $1.90
- compared with -$0.57 a year earlier